Most up-to-date research on "Global Hyperphosphatemia Drugs Market 2015-2019" to its huge collection of research reports.
Product Synopsis
About hyperphosphatemiaPhosphorus is an important element for normal physiologic functions such as bone construction, nerve function, and muscle contraction. About 85% of phosphorus is stored in the bones and different tissues in the body. The excess phosphorus is eliminated from the body by the urinary system. The normal phosphate level in the blood is 3-4 mg/dL. Electrolytic disturbance resulting in high levels of phosphate in the blood causes hyperphosphatemia. Individuals with chronic kidney diseases have a decreased glomerular filtration rate and increased serum phosphate levels. The high phosphate levels in the serum lower calcium levels because of phosphate precipitation by calcium ions, leading to calcification of vascular tissues and heart diseases. Aluminum-, calcium-, magnesium-, and iron-based and aluminum-free, calcium-free phosphate binders are used to treat the condition.
Market analysts forecast the global hyperphosphatemia drugs market to grow at a CAGR of 10.71% over the period 2014-2019.
Browse Detail Report With TOC @ http://www.researchmoz.us/global-hyperphosphatemia-drugs-market-2015-2019-report.html
Covered in this Report
In this report, Technavio covers the present scenario and growth prospects of the global hyperphosphatemia drugs market for 2015-2019. To calculate the market size, the report considers revenue generated from the sales of branded, generic, OTC, and off-label drugs used for treating hyperphosphatemia.
New report, Global Hyperphosphatemia Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global hyperphosphatemia drugs market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key regions
Americas
APAC
EMEA
Key vendors
Fresenius Medical Care
Keryx Biopharmaceuticals
Sanofi
Shire
Vifor Pharma
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=sample&repid=317258
Other prominent vendors
Alkem
Amgen
Ardelyx
AstraZeneca
Baxter
Bayer
Chugai Pharmaceutical
Japan Tobacco
Kissei Pharmaceutical
Kyowa Hakko Kirin
Mylan
Natco
Novartis
Opko Health
Panion & BF Biotech
Roxane Laboratories
Sandoz
Synthon
Torri Pharmaceutical
Market driver
Increased number of people undergoing dialysis
For a full, detailed list, view our report
Market challenge
Non-adherence to treatment regimens
For a full, detailed list, view our report
Market trend
Patient assistance programs
For a full, detailed list, view our report
For Market Research Latest Reports Visit @ http://www.researchmoz.us/latest-report.html
Key questions answered in this report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
Mr. Nachiket,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Product Synopsis
About hyperphosphatemiaPhosphorus is an important element for normal physiologic functions such as bone construction, nerve function, and muscle contraction. About 85% of phosphorus is stored in the bones and different tissues in the body. The excess phosphorus is eliminated from the body by the urinary system. The normal phosphate level in the blood is 3-4 mg/dL. Electrolytic disturbance resulting in high levels of phosphate in the blood causes hyperphosphatemia. Individuals with chronic kidney diseases have a decreased glomerular filtration rate and increased serum phosphate levels. The high phosphate levels in the serum lower calcium levels because of phosphate precipitation by calcium ions, leading to calcification of vascular tissues and heart diseases. Aluminum-, calcium-, magnesium-, and iron-based and aluminum-free, calcium-free phosphate binders are used to treat the condition.
Market analysts forecast the global hyperphosphatemia drugs market to grow at a CAGR of 10.71% over the period 2014-2019.
Browse Detail Report With TOC @ http://www.researchmoz.us/global-hyperphosphatemia-drugs-market-2015-2019-report.html
Covered in this Report
In this report, Technavio covers the present scenario and growth prospects of the global hyperphosphatemia drugs market for 2015-2019. To calculate the market size, the report considers revenue generated from the sales of branded, generic, OTC, and off-label drugs used for treating hyperphosphatemia.
New report, Global Hyperphosphatemia Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global hyperphosphatemia drugs market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key regions
Americas
APAC
EMEA
Key vendors
Fresenius Medical Care
Keryx Biopharmaceuticals
Sanofi
Shire
Vifor Pharma
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=sample&repid=317258
Other prominent vendors
Alkem
Amgen
Ardelyx
AstraZeneca
Baxter
Bayer
Chugai Pharmaceutical
Japan Tobacco
Kissei Pharmaceutical
Kyowa Hakko Kirin
Mylan
Natco
Novartis
Opko Health
Panion & BF Biotech
Roxane Laboratories
Sandoz
Synthon
Torri Pharmaceutical
Market driver
Increased number of people undergoing dialysis
For a full, detailed list, view our report
Market challenge
Non-adherence to treatment regimens
For a full, detailed list, view our report
Market trend
Patient assistance programs
For a full, detailed list, view our report
For Market Research Latest Reports Visit @ http://www.researchmoz.us/latest-report.html
Key questions answered in this report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
Mr. Nachiket,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
No comments:
Post a Comment